TVTX insider trading
Travere Therapeutics, Inc.
In the past 36 days, 8 insiders sold $66.3M.
Insider purchases
No open-market purchases by insiders in this period.
Insider sales
| Insider | Value | Holdings | Plan | Traded / filed |
|---|---|---|---|---|
Eric M Dube CHIEF EXECUTIVE OFFICER |
$25.4M 400,000 sh @ $63.48 |
−48.0% | Pre-scheduled | Sep 15, 2026 Filed Sep 17, 2026 |
Peter Heerma EVP, CHIEF COMMERCIAL OFFICER |
$17.9M 283,189 sh @ $63.06 |
−70.8% | Pre-scheduled | Sep 15, 2026 Filed Sep 17, 2026 |
William E. Rote Chief Research Officer |
$13.1M 209,048 sh @ $62.83 |
−68.0% | Pre-scheduled | Sep 15, 2026 Filed Sep 17, 2026 |
Christopher R. Cline CHIEF FINANCIAL OFFICER |
$3.1M 50,508 sh @ $62.34 |
−36.6% | Pre-scheduled | Sep 15, 2026 Filed Sep 17, 2026 |
Jula Inrig EVP, Head of R&D & CMO |
$2.8M 44,674 sh @ $62.34 |
−30.8% | Pre-scheduled | Sep 15, 2026 Filed Sep 17, 2026 |
Elizabeth E Reed Chief Legal Officer and GC |
$2.3M 37,500 sh @ $62.34 |
−26.2% | Pre-scheduled | Sep 15, 2026 Filed Sep 17, 2026 |
Sandra Calvin SVP, CHIEF ACCOUNTING OFFICER |
$335K 5,375 sh @ $62.33 |
−11.3% | Pre-scheduled | Sep 15, 2026 Filed Sep 17, 2026 |
Jeffrey A Meckler Director |
$1.3M 20,000 sh @ $67.31 |
−17.9% | Pre-scheduled | Sep 10, 2026 Filed Sep 11, 2026 |